Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imrecoxib and Warfarin Interaction Study
NCT02426060Phase 1Unknown
- Sponsor
- Hengrui
- Start
- Jan 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of imrecoxib in osteoarthritis (OA), sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration of Warfarin, Time to Maximum Plasma Concentration of Warfarin and 1 more. Status: unknown.
02
Drugs
imrecoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02426060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426060.